Business Description
Hangzhou Alltest Biotech Co Ltd
ISIN : CNE1000053G6
Share Class Description:
SHSE:688606: Class ACompare
Compare
Traded in other countries / regions
688606.China IPO Date
2021-03-25Description
Hangzhou Alltest Biotech Co Ltd is engaged in the research and development, production and sales of in vitro diagnostic reagents.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 314.16 | |||||
| Equity-to-Asset | 0.93 | |||||
| Debt-to-EBITDA | 0.03 | |||||
| Interest Coverage | 346.72 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 13.55 | |||||
| Beneish M-Score | -2.82 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -20.5 | |||||
| 3-Year EBITDA Growth Rate | -39.6 | |||||
| 3-Year EPS without NRI Growth Rate | -45.4 | |||||
| 3-Year Book Growth Rate | 43.7 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 43.37 | |||||
| 9-Day RSI | 47.71 | |||||
| 14-Day RSI | 50.57 | |||||
| 6-1 Month Momentum % | 19.14 | |||||
| 12-1 Month Momentum % | -13.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 11.02 | |||||
| Quick Ratio | 10.46 | |||||
| Cash Ratio | 9.71 | |||||
| Days Inventory | 168.69 | |||||
| Days Sales Outstanding | 47.88 | |||||
| Days Payable | 95.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.35 | |||||
| Dividend Payout Ratio | 0.53 | |||||
| Forward Dividend Yield % | 4.35 | |||||
| 5-Year Yield-on-Cost % | 4.35 | |||||
| 3-Year Average Share Buyback Ratio | -9.9 | |||||
| Shareholder Yield % | 4.56 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 54.69 | |||||
| Operating Margin % | 28.03 | |||||
| Net Margin % | 34.02 | |||||
| FCF Margin % | 6.49 | |||||
| ROE % | 7.24 | |||||
| ROA % | 6.7 | |||||
| ROIC % | 17.2 | |||||
| ROC (Joel Greenblatt) % | 33.71 | |||||
| ROCE % | 7.99 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 19.75 | |||||
| PE Ratio without NRI | 24.37 | |||||
| Price-to-Owner-Earnings | 78.5 | |||||
| PEG Ratio | 0.71 | |||||
| PS Ratio | 6.71 | |||||
| PB Ratio | 1.41 | |||||
| Price-to-Tangible-Book | 1.45 | |||||
| Price-to-Free-Cash-Flow | 102.26 | |||||
| Price-to-Operating-Cash-Flow | 18.13 | |||||
| EV-to-EBIT | 9.17 | |||||
| EV-to-EBITDA | 9.17 | |||||
| EV-to-Revenue | 3.46 | |||||
| EV-to-FCF | 53.22 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.49 | |||||
| Price-to-Graham-Number | 1.25 | |||||
| Price-to-Net-Current-Asset-Value | 2 | |||||
| Price-to-Net-Cash | 2.3 | |||||
| Earnings Yield (Greenblatt) % | 10.91 | |||||
| FCF Yield % | 0.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hangzhou Alltest Biotech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 812.783 | ||
| EPS (TTM) (Â¥) | 3.49 | ||
| Beta | 1.03 | ||
| Volatility % | 47.78 | ||
| 14-Day RSI | 50.57 | ||
| 14-Day ATR (Â¥) | 3.290301 | ||
| 20-Day SMA (Â¥) | 69.5555 | ||
| 12-1 Month Momentum % | -13.09 | ||
| 52-Week Range (Â¥) | 45.17 - 81.1 | ||
| Shares Outstanding (Mil) | 79.28 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hangzhou Alltest Biotech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hangzhou Alltest Biotech Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hangzhou Alltest Biotech Co Ltd Frequently Asked Questions
What is Hangzhou Alltest Biotech Co Ltd(SHSE:688606)'s stock price today?
The current price of SHSE:688606 is ¥68.92. The 52 week high of SHSE:688606 is ¥81.10 and 52 week low is ¥45.17.
When is next earnings date of Hangzhou Alltest Biotech Co Ltd(SHSE:688606)?
The next earnings date of Hangzhou Alltest Biotech Co Ltd(SHSE:688606) is .
Does Hangzhou Alltest Biotech Co Ltd(SHSE:688606) pay dividends? If so, how much?
The Dividend Yield %  of Hangzhou Alltest Biotech Co Ltd(SHSE:688606) is 4.35% (As of Today), Highest Dividend Payout Ratio of Hangzhou Alltest Biotech Co Ltd(SHSE:688606) was 3.65. The lowest was 0.13. And the median was 0.19. The  Forward Dividend Yield % of Hangzhou Alltest Biotech Co Ltd(SHSE:688606) is 4.35%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers